Sodium ion/hydrogen ion exchange inhibition: A new pharmacologic approach to myocardial ischemia and reperfusion injury

Journal of Clinical Pharmacology

Volumn 38, Issue 10, 1998, Pages 887-897

  Levitsky, Josh ^a   Gurell, Daniel ^a   Frishman, William H ^b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

(3 METHYLSULFONYL 4 PIPERIDINOBENZOYL)GUANIDINE METHANESULFONATE; 5 (N ETHYL N ISOPROPYL)AMILORIDE; 5 (N ISOBUTYL N METHYL)AMILORIDE; 5 (N,N DIMETHYL)AMILORIDE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATE; AMILORIDE; AMILORIDE DERIVATIVE; CALCIUM; CARIPORIDE; CREATINE KINASE; GLYCOGEN; HEXAMETHYLAMILORIDE; LACTATE DEHYDROGENASE; LACTIC ACID; MESSENGER RNA; PHOSPHATE; PHOSPHATIDYLINOSITIDE; PROTEIN INHIBITOR; PROTON; SODIUM ION; UNCLASSIFIED DRUG;

ANGINA PECTORIS; CELL PH; CLINICAL TRIAL; DRUG EFFICACY; HEART ARRHYTHMIA; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PROTON SODIUM EXCHANGE; REPERFUSION INJURY; REVIEW;

EID: 0031727820     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1552-4604.1998.tb04383.x     Document Type: Review

References (74)

1. Kaila K, Vaughan-Jones RD: Influence of sodium-hydrogen exchange on intracellular pH, sodium and tension in sheep cardiac Purkinje fibres. J Physiol (Lond) 1987;390:93-118.
2. Allen DG, Orchard CH: Myocardial contractile function during ischemia and hypoxia. Circ Res 1987;60:153-168.
3. Scholz W, Albus U: Potential of selective sodium-hydrogen exchange inhibitors in cardiovascular therapy. Cardiovasc Res 1995;29:184-188.
4. + exchanger: an update on structure, regulation, and cardiac physiology. Biochem J 1993; 296:273-285.
5. Mahnensmith RL, Aronson PS: The plasma membrane sodiumhydrogen exchanger and its role in physiological and pathophysiological processes. Circ Res 1985;56:773-778.
6. + exchange in cardiac physiology and pathophysiology: mediation of myocardial reperfusion injury by the pH paradox. Cardiovasc Res 1993;27:915-924.
7. + exchange and its inhibition in cardiac ischemia and reperfusion. Basic Res Cardiol 1993;88:443-455.
8. Pierce GN, Czubryt MP: The contribution of ionic imbalance to ischemia/reperfusion-induced injury. J Mol Cell Cardiol 1995;27: 53-63.
9. + exchange in isolated renal brush-border membrane vesicles in response to metabolic acidosis. J Biol Chem 1984;259:13224-13227.
10. + antiporter activity in renal cortical apical membrane vesicles. Am J Physiol 1991;260:F130-F137.
11. + antiporter mRNA levels in response to respiratory and metabolic acidosis. J Clin Invest 1991;87:747-751.
12. + exchangers in LLC-PK1 renal epithelial cells. Am J Physiol 1992;263:F83-F88.
13. Avkiran M, Ibuki C: Reperfusion-induced arrhythmias: a role for washout of extracellular protons? Circ Res 1992;71: 1429-1440.
14. Opie LH, Coetzee WA: Role of calcium ions in reperfusion arrhythmias: relevance to pharmacologic intervention. Cardiovasc Drugs Ther 1988;2:623-636.
15. Panagiotopoulos S, Daly MJ, Nayler WG: Effect of acidosis and alkalosis on postischemic Ca gain in isolated rat heart. Am J Physiol 1990;258:H821-H828.
16. Anderson SE, Murphy E, Steenbergen C, London RE, Cala PM: Na-H exchange in myocardium: effects of hypoxia and acidification on Na and Ca. Am J Physiol 1990;259:C940-C948.
17. + exchange inhibition in global ischemia (abstract). J Mol Cell Cardiol 1989;21:1226.
18. + exchange system in the pathogenesis of myocardial ischemia-reperfusion damage. Science China 1991;34:599-605.
19. Neely JR, Morgan HE: Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle. Ann Rev Physiol 1974;36:413-459.
20. Rouslin W: Protonic inhibition of the mitochondrial oligomycin-sensitive adenosine 5′-triphosphatase in ischemic and autolyzing cardiac muscle. J Biol Chem 1983;258:9657-9661.
21. Rouslin W, Erickson JL: Factors affecting loss of mitochondrial functioning in autolyzing cardiac muscle. J Mol Cell Cardiol 1986;18:1187-1195.
22. Ellis D, MacLeod KT: Sodium-dependent control of intracellular pH in Purkinje fibers of sheep heart. J Physiol 1985;259:81-105.
23. + antiporter in human neutrophil NADPH-oxidase activation. J Leukocyte: Biol 1988;43:183-186.
24. Scheufler E, Henrichs M, Guttmann I, Mozes A, Wilffert B: Effect of Na/H exchange inhibitor ethyl-isopropyl-amiloride (EIPA) during ischaemia and reperfusion (abstract). Br J Pharmacol 1993;108:118P.
25. + exchange inhibitor and its effects in cardiac ischemia. Br J Pharmacol 1993;109:562-568.
26. + exchange inhibitors in cardiac ischemia. J Mol Cell Cardiol 1992;24:731-739.
27. + concentration. J Biol Chem 1984;259:8880-8885.
28. Lazdunski M, Frelin C, Vigne P: The sodium/hyrogen exchange system in cardiac cells: its biochemical and pharmacological properties and its role in regulating internal concentrations of sodium and internal pH. J Mol Cell Cardiol 1985;17:1029-1042.
29. Blanchard EM, Solaro RJ: Inhibition of the activation and troponin calcium binding of dog cardiac myofibrils by acidic pH. Circ Res 1984;55:382-391.
30. Fabiato A, Fabiato F: Effects of pH on the myofilaments and the sarcoplasmic reticulum of skinned cells from cardiac and skeletal muscle. J Physiol 1978;276:233-255.
31. 2+-regulated ATPase of cardiac and white skeletal myofibrils. J Mol Cell Cardiol 1979;11:611-617.
32. Mattiazzi AR, Cingolani HE, Spacapan de Castuma E: Relationship between calcium and hydrogen ions in heart muscle. Am J Physiol 1979;237:H497-H503.
33. Schadler M: Proportionale Aktivierung von ATPase Aktivitat und Kontraktionsspannung durch Caliumionen in isolierten kontraktilen Strukturen verschiedner Muskelarten. Pfluegers Arch 1967;296:70-90.
34. Steenbergen C, Murphy E, Levy L, London RE: Elevation in cytosolic free calcium concentration early in myocardial ischemia in perfused rat heart. Circ Res 1987;60:700-707.
35. + exchange. Am J Physiol 1988; 255:H608-H615.
36. Moffat MP, Karmazyn M: Protective effects of the potent Na/H exchange inhibitor methylisobutyl amiloride against post-ischemic contractile dysfunction in rat and guinea-pig hearts. J Mol Cell Cardiol 1993;25:959-971.
37. Murphy E, Perlman M, London RE, Steenbergen C: Amiloride delays the ischemia-induced rise in cytosolic calcium. Circ Res 1991;68:1250-1258.
38. + exchanger and reperfusion-induced ventricular arrhythmias in isolated perfused heart: possible role of amiloride. Mol Cell Biochem 1993;119:151-157.
39. + exchange inhibitors against cardiac injury produced by ischemia/ reperfusion, hypoxia/reoxygenation, and the calcium paradox. J Cardiovasc Pharmacol 1993;21:172-178.
40. Myers ML, Mathur S, Li G-H, Karmazyn M: Sodium-hydrogen exchange inhibitors improve postischaemic recovery of function in the perfused rabbit heart. Cardiovasc Res 1995;29:209-214.
41. Koike A, Akita T, Hotta Y, Takeya K, Kodama I. Murase M, et al: Protective effects of dimethyl amiloride against postischemic myocardial dysfunction in rabbit hearts: phosphorus 31-nuclear magnetic resonance measurements of intracellular pH and cellular energy. J Thorac Cardiovasc Surg 1996;112:765-778.
42. Khandoudi N, Laville M-P, Bril A: Protective effect of sodium/hydrogen exchange inhibitors during global low-flow ischemia. J Cardiovasc Pharmacol 1996;28:540-546.
43. + exchange and reperfusion arrhythmias: protection by intracoronary infusion of a novel inhibitor. Am J Physiol 1994;267:H2430-H2440.
44. + antiporter inhibitor on postischemic reperfusion in pig heart. J Cardovasc Pharmacol 1994;23:72-78.
45. 2+ overload in isolated perfused rabbit heart. Circulation 1994;89:2787-2798.
46. + exchange inhibition in ischemic, reperfused porcine hearts. Circulation 1995;92:912-918.
47. Scholz W, Albus U, Counillon L, Gogelein H, Lang H-J, Linz W, et al: Protective effects of HOE 642, a selective sodium-hydrogen exchange subtype 1 inhibitor, on cardiac ischaemia and reperfusion. Cardiovasc Res 1995;29:260-268.
48. + exchange inhibition in regionally ischemic, reperfused porcine hearts. J Cardiovasc Pharmacol 1997;30:235-240.
49. Meng H-P, Pierce GN: Involvement of sodium in the protective effect of 5-(N,N- dimethyl)-amiloride on ischemia-reperfusion injury in isolated rat ventricular wall. J Pharmacol Exp Ther 1991;256:1094-1100.
50. 2+ exchange. Circ Res 1989;65:1045-1056.
51. + exchange. Circ Res 1990;66:1012-1022.
52. Duff HJ, Brown CE, Cragoe EJ, Rahmeberg M: Antiarrhythmic activity of amiloride: mechanisms. J Cardiovasc Pharmacol 1991; 17:879-888.
53. Meng H-P, Pierce GN: Protective effects of 5-(N,N-dimethyl) amiloride on ischemia-reperfusion injury in hearts. Am J Physiol 1990;258:H1615-H1619.
54. Meng H-P, Maddaford TG, Pierce GN: Effect of amiloride and selected analogues on postischemic recovery of cardiac contractile function. Am J Physiol 1993;265:H1831-H1835.
55. + exchange inhibitor HOE 694. Ann Thorac Surg 1996;61:1394-1399.
56. + exchange prevents ventricular fibrillation and preserves function in porcine stunned myocardium (abstract). J Mol Cell Cardiol 1992;24:S92.
57. Duff HJ, Rahmberg M, Lester WM: Amiloride: antiarrhythmic and electrophysiologic activity in the dog. Circulation 1988;78: 1469-1477.
58. Duff HJ, Mitchell LB, Kavanagh KM, Manyari DE, Gillis AM, Wyse DG: Amiloride: antiarrhythmic and electrophysiologic actions in patients with sustained ventricular tachycardia. Circulation 1989;79:1257-1263.
59. Myers MG: Diuretic therapy and ventricular arrhythmias in persons 65 years of age and older. Am J Cardiol 1990;65:599-603.
60. Holland OB, Kuhnert L, Pollard J, Padia M, Anderson RJ, Blomquist G: Ventricular ectopic activity with diuretic therapy. Am J Hypertension 1988;1:380-385.
61. Lumme JA, Jounela AJ: Cardiac arrhythmias in hypertensive outpatients on various diuretics: correlation between incidence and serum potassium and magnesium levels. Ann Clin Res 1986; 18:186-190.
62. + exchange inhibition during either the ischaemic or the reperfusion decreases reperfusion damage in rat heart (abstract). Eur Heart J 1993;14:95.
63. Koren W, Koldanov R, Peleg E, Rabinowitz B, Rosenthal T: Enhance red cell sodium-hydrogen exchange in microvascular angina. Eur Heart J 1997;18:1296-1299.
64. + antiport in type I diabetic patients with albuminuria. Diabetologia 1990;33:278-289.
65. Postnov YV, Kravtsov GM, Orlov SN, Pokudin NI, Postnov IY, Kotelevtsev YV: Effect of protein kinase C activation on cytoskeleton and cation transport in human erythrocytes. Hypertension 1988;12:267-273.
66. Dean JD, Jones CJH, Hutchinson SF: Hyperinsulinemia and microvascular angina ('syndrome X'). Lancet 1991;337:456-457.
67. + exchange and other ion-transport systems in erythrocytes of essential hypertensives and spontaneously hypertensive rats: a comparative analysis. J Hypertension 1989;7:781-788.
68. + exchange activity in the spontaneously hypertensive perfused rat heart. J Mol Cell Cardiol 1995;27:1475-1481.
69. Canessa M, Morgan K, Godszer R, Moore TJ, Spalvins A: Kinetic abnormalities of the red blood cell sodium-proton exchange in hypertensive patients. Hypertension 1991;17:340-348.
70. + antiport in essential hypertension. J Hypertension 1990; 8:533-537.
71. + exchanger is stimulated and cell volume increased in lymphocytes from patients with essential hypertension. J Hypertension 1991;8:533-537.
72. + exchange activity in normotensive and hypertensive subjects: effect of enalapril therapy upon antiport activity. J Hypertension 1992;10:839-847.
73. + exchanger overactivity in essential hypertension. Am J Hypertension 1997;10:84-93.
74. Nofer J-R, Tepel M, Kehrel B, Wierwille S, Walter M, Seedorf U, et al: Low-density lipoproteins inhibit the antiport in human platelets: a novel mechanism enhancing platelet activity in hypercholesterolemia. Circulation 1997;95:1370-1377.